Crossmark

A double-blind, randomized controlled pilot study comparing the safety of intracameral levofloxacin and intracameral cefazolin in patients undergoing cataract surgery

Crossref DOI link: https://doi.org/10.1038/s41598-025-17553-6

Published Online: 2025-10-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koh, Yan Tong

Yeo, Tun Kuan

Toh, Zhi Hong

Wong, John Xin Hao

Ngo, Wei Kiong

Fam, Han Bor

Pek, Don Chern Kuok
Funding

Funding for this research was provided by:

Santen Pharmaceutical Asia Pte. Ltd
License Information

Text and Data Mining valid from 2025-10-02

Version of Record valid from 2025-10-02
More Information

Article History

Received: 11 March 2025

Accepted: 25 August 2025

First Online: 2 October 2025

Declaration

:

: The authors declare no competing interests.

: Ethical approval was obtained from the National Healthcare Group Domain Specific Review Board.

: Written informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below